0001732825-22-000003.txt : 20221102 0001732825-22-000003.hdr.sgml : 20221102 20221102090150 ACCESSION NUMBER: 0001732825-22-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20221102 DATE AS OF CHANGE: 20221102 EFFECTIVENESS DATE: 20221102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Flow Pharma, Inc. CENTRAL INDEX KEY: 0001732825 IRS NUMBER: 770511984 STATE OF INCORPORATION: DE FISCAL YEAR END: 1130 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-463578 FILM NUMBER: 221352428 BUSINESS ADDRESS: STREET 1: 45 QUAIL COURT 300 CITY: WALNUT CREEK STATE: CA ZIP: 94596 BUSINESS PHONE: 4152382300 MAIL ADDRESS: STREET 1: 45 QUAIL COURT 300 CITY: WALNUT CREEK STATE: CA ZIP: 94596 D 1 primary_doc.xml X0708 D LIVE 0001732825 Flow Pharma, Inc. 4829 Galaxy Parkway Suite K Warrensville Heights OH OHIO 44128 1-216-350-8361 DELAWARE None None Corporation true Reid Martin Rubsamen 4829 Galaxy Parkway Suite K Warrensville Heights OH OHIO 44128 Executive Officer Director Tikoes Blankenberg 4829 Galaxy Parkway Suite K Warrensville Heights OH OHIO 44128 Director Thomas Barnish 4829 Galaxy Parkway Suite K Warrensville Heights OH OHIO 44128 Executive Officer Gil Van Bokkelen 4829 Galaxy Parkway Suite K Warrensville Heights OH OHIO 44128 Executive Officer Stephen Farr 4829 Galaxy Parkway Suite K Warrensville Heights OH OHIO 44128 Director Tom Brady 4829 Galaxy Parkway Suite K Warrensville Heights OH OHIO 44128 Executive Officer Charles Vincent Herst 4829 Galaxy Parkway Suite K Warrensville Heights OH OHIO 44128 Executive Officer Pamela Steele 4829 Galaxy Parkway Suite K Warrensville Heights OH OHIO 44128 Director Babatunde Otulana 4829 Galaxy Parkway Suite K Warrensville Heights OH OHIO 44128 Director Biotechnology Decline to Disclose 06c false 2022-10-20 false true false 0 Carleton McKenna Advisors, LLC 159230 None None 1801 East Ninth Street Suite 1425 Cleveland OH OHIO 44114 All States true 10500000 180000 10320000 false 8 0 true 500000 true 0 false Flow Pharma, Inc. Reid Rubsamen Reid Rubsamen Chief Executive Officer 2022-11-02